Your session is about to expire
← Back to Search
Vasodilator
inhaled nitric oxide for Cardiac Arrest
Phase < 1
Waitlist Available
Led By Jignesh K Patel, MD
Research Sponsored by Stony Brook University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up upto 24 weeks
Awards & highlights
Summary
This trial will test whether inhaling nitric oxide can improve resuscitation from cardiac arrest and improve short-term survival and neurologic outcome.
Eligible Conditions
- Cardiac Arrest
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ upto 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~upto 24 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in cerebral oxygenation (rSO2)
Rate of return of spontanueous circulation (ROSC)
Secondary study objectives
Neurologic outcomes at hospital discharge
short term survival
Trial Design
1Treatment groups
Experimental Treatment
Group I: inhaled nitric oxideExperimental Treatment1 Intervention
Inhaled Nitric Oxide at 40 ppm will be administered in adults who suffer in hospital cardiac arrest. The administration of inhaled nitric oxide at 40 ppm will be provided upto 24 hours once ROSC is achieved.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nitric Oxide
FDA approved
Find a Location
Who is running the clinical trial?
Stony Brook UniversityLead Sponsor
222 Previous Clinical Trials
41,828 Total Patients Enrolled
1 Trials studying Cardiac Arrest
800 Patients Enrolled for Cardiac Arrest
Jignesh K Patel, MDPrincipal InvestigatorStony Brook University
Share this study with friends
Copy Link
Messenger